Hot FLASH - Director of Office of Generic Drugs Resigns
Written by Bob Pollock • March 13, 2013
Only eight months after taking the helm of the Office of Generic Drugs, Gregory P. Geba M.D., M.P.H. notified his staff that he will resign as of close of business March 15, 2013. While we have not heard of any specific reason for his resignation, one could speculate that Dr. Geba was not happy with the announced organizational changes affecting the OGD. While, on one hand, being elevated to Super Office Status, on the other, the OGD chemists appear to be heading out of OGD into the Office of Drug Product Quality. This, which could potentially reduce immediate OGD staff by almost 50%, could be a reason for the move.
At this critical time for OGD with GDUFA implementation in full swing, we will now have to see how the Agency responds.